{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:36:36Z","timestamp":1792794996082,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Domestic First-class Discipline Construction Project of Chinese Medicine of Hunan University of Chinese Medicine","award":["4901-020000200207"],"award-info":[{"award-number":["4901-020000200207"]}],"id":[{"id":"https:\/\/ror.org\/01tsmvz08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key Project of Hunan Provincial Administration of Traditional Chinese Medicine","award":["A2024027"],"award-info":[{"award-number":["A2024027"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The application of Xiaoer Feike Granules (XFG) in respiratory diseases has garnered significant attention. This study aims to quantitatively assess the efficacy and safety of XFG when combined with azithromycin for the treatment of Mycoplasma pneumoniae pneumonia (MPP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive search of 8 public databases was conducted for relevant clinical trials published before July 1, 2024. The meta-analysis and trial sequential analysis were performed on the included studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Compared with azithromycin alone, the combination of XFG and azithromycin significantly improved the clinical effective rate (RR\u2005=\u20051.17, 95% CI\u2005=\u20051.13\u20131.22,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), and reduced the duration of fever (MD\u2005=\u2005\u22121.67, 95% CI\u2005=\u2005\u22121.83 to \u22121.50,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), cough (MD\u2005=\u2005\u22121.85, 95% CI\u2005=\u2005\u22122.28 to \u22121.43,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), wheezing (MD\u2005=\u2005\u22122.07, 95% CI\u2005=\u2005\u22122.51 to \u22121.64,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), and rales (MD\u2005=\u2005\u22122.34, 95% CI\u2005=\u2005\u22123.11 to \u22121.57,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001). It also lowered inflammatory markers, including C-reactive protein (MD\u2005=\u2005\u22128.22, 95% CI\u2005=\u2005\u221211.27 to \u22125.17,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), procalcitonin (MD\u2005=\u2005\u22120.50, 95% CI\u2005=\u2005\u22120.57 to \u22120.43,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), and tumor necrosis factor \u03b1 (MD\u2005=\u2005\u22120.61, 95% CI\u2005=\u2005\u22120.72 to \u22120.49,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), while No significant difference was found in interleukin-6 levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.11). In terms of safety, the combination of XFG and azithromycin significantly reduced the incidence of total adverse events (RR\u2005=\u20050.40, 95% CI\u2005=\u20050.19\u20130.84,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.02), nausea and vomiting (RR\u2005=\u20050.42, 95% CI\u2005=\u20050.19\u20130.94,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.03), abdominal pain and diarrhea (RR\u2005=\u20050.31, 95% CI\u2005=\u20050.13\u20130.75,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.009), and erythra (RR\u2005=\u20050.27, 95% CI\u2005=\u20050.09\u20130.79,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.02), with no significant differences in dizziness and headache (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.24). Egger test indicated no evidence of publication bias in these outcomes (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Compared with azithromycin alone, XFG combined with azithromycin offers faster symptom resolution, reduced inflammation, and fewer adverse events. This combination may represent a safe and effective therapeutic strategy for MPP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044287","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:00:12Z","timestamp":1757970012000},"page":"e44287","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of Xiaoer Feike Granules combined with azithromycin for Mycoplasma pneumoniae pneumonia: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiaoqiong","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Respiratory, The 921st Hospital of the Joint Logistic Support Force of the Chinese People\u2019s Liberation Army, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Respiratory, The 921st Hospital of the Joint Logistic Support Force of the Chinese People\u2019s Liberation Army, Changsha, Hunan, China"},{"name":"Department of Paediatrics, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Tong","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"9740841","DOI":"10.1155\/2020\/9740841","article-title":"Xiao\u2019er Xiaoji Zhike oral liquid combined with azithromycin for Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.","volume":"2020","author":"Zhang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12879-020-4810-9","article-title":"Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"154402","DOI":"10.1016\/j.phymed.2022.154402","article-title":"Efficacy and safety of reduning injection combined with azithromycin in the treatment of Mycoplasma pneumonia among children: a systematic review and meta-analysis.","volume":"106","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"e0195288","DOI":"10.1371\/journal.pone.0195288","article-title":"Clinical manifestations in infants and children with Mycoplasma pneumoniae infection.","volume":"13","author":"S\u00f8ndergaard","year":"2018","journal-title":"PLoS One"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anpedi.2018.07.016","article-title":"Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015.","volume":"91","author":"Aguilera-Alonso","year":"2019","journal-title":"An Pediatr (Engl Ed)"},{"key":"R6-20260923","first-page":"156","article-title":"Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children.","volume":"36","author":"Han","year":"2020","journal-title":"Pak J Med Sci"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","article-title":"Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.","volume":"16","author":"Lee","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"e008194","DOI":"10.1136\/bmjopen-2015-008194","article-title":"Use and safety of azithromycin in neonates: a systematic review.","volume":"5","author":"Smith","year":"2015","journal-title":"BMJ Open"},{"key":"R9-20260923","first-page":"3310","article-title":"Effects of Xiaoer Feike granule and azithromycin on tidal breathing pulmonary function, Th1\/Th2 immune balance and serum APC, IL-1R1 levels in children with MPP.","volume":"21","author":"Fu","year":"2021","journal-title":"Prog Mod Biomed"},{"key":"R10-20260923","first-page":"110","article-title":"Effect of Xiaoer Feike granules combined with azithromycin in children with Mycoplasma pneumonia.","volume":"31","author":"Chai","year":"2023","journal-title":"Clin Res"},{"key":"R11-20260923","first-page":"25","article-title":"Observation of integrated traditional and western medicine treating 31 cases of child prolonged mycoplasmal pneumonia.","volume":"11","author":"Xu","year":"2015","journal-title":"J Pediatr Tradit Chin"},{"key":"R12-20260923","first-page":"1955","article-title":"Clinical study on the effect of CRP and interleukin-6 in children with Mycoplasma pneumonia treated by pediatric pulmonary cough particles.","volume":"40","author":"Yu","year":"2019","journal-title":"Jilin Med J"},{"key":"R13-20260923","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematicreviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R14-20260923","first-page":"1304","article-title":"Expert consensus on diagnosis and treatment of mycoplasma pneumoniae pneumonia in children (2015).","volume":"30","year":"2015","journal-title":"Chin J Appl Clin Pediatr"},{"key":"R15-20260923","first-page":"46","article-title":"Study on the efficacy and safety of Xiaoer Feike granule combined with azithromycin in the treatment of mycoplasma pneumonia in children.","volume":"8","author":"Duan","year":"2019","journal-title":"Health Horizon"},{"key":"R16-20260923","first-page":"369","article-title":"Effect of Xiaoer Feike granule on the treatment of mycoplasma pneumonia in children and its influence on the level of serum activated protein C and interleukin-1 receptor type 1.","volume":"33","author":"Liao","year":"2018","journal-title":"Mater Child Health Care China"},{"key":"R17-20260923","first-page":"61","article-title":"Effect of Xiaoer Feike granule combined with azithromycin on Mycoplasma pneumonia in children and its influence on serum inflammatory factors in children.","volume":"27","author":"Lin","year":"2020","journal-title":"Capital Food Med"},{"key":"R18-20260923","first-page":"183","article-title":"Analysis of the curative effect of azithromycin combined with Xiaoer Feike granule in the treatment of mycoplasma pneumonia in children.","volume":"38","author":"Ma","year":"2020","journal-title":"J Huaihai Med"},{"key":"R19-20260923","first-page":"18","article-title":"Clinical observation on the treatment of Mycoplasma pneumonia in children with Feike granule and azithromycin.","volume":"14","author":"Mei","year":"2022","journal-title":"Res Integrat Tradit Chin West Med"},{"key":"R20-20260923","first-page":"5658","article-title":"Effect of Xiaoer Feike granule and azithromycin in the treatment of mycoplasma pneumonia in children and its influence on lung function and Th1\/Th2 immune balance.","volume":"34","author":"Song","year":"2019","journal-title":"Mater Child Health Care China"},{"key":"R21-20260923","first-page":"95","article-title":"Effects of pediatric pulmonary cough granules combined with azithromycin in treatment of children with Mycoplasma pneumonia.","volume":"33","author":"Wang","year":"2021","journal-title":"Med J Chin Peoples Health"},{"key":"R22-20260923","first-page":"11","article-title":"Analysis of the combined application value of azithromycin and Xiaoerfeike Granules in the clinical treatment of children with mycoplasma.","volume":"24","author":"Yang","year":"2021","journal-title":"Womens Health Res"},{"key":"R23-20260923","first-page":"74","article-title":"Clinical study on Xiaoer Feike granules combined with azithromycin for Mycoplasma pneumonia in children and its effect on expression of inflammatory factors.","volume":"52","author":"Zhang","year":"2020","journal-title":"New Chin Med"},{"key":"R24-20260923","first-page":"66","article-title":"Clinical effect of Xiaoer Feike granule on Mycoplasma pneumoniae pneumonia in children and its influence on inflammatory factors.","volume":"14","author":"Zou","year":"2021","journal-title":"Chin J Clin Rational Drug Use"},{"key":"R25-20260923","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13052-022-01362-y","article-title":"The efficacy and safety of minocycline as adjuvant therapy in refractory mycoplasma pneumonia in Chinese children: a meta-analysis.","volume":"48","author":"Shen","year":"2022","journal-title":"Ital J Pediatr"},{"key":"R26-20260923","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13052-014-0104-4","article-title":"Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis.","volume":"40","author":"Medjo","year":"2014","journal-title":"Ital J Pediatr"},{"key":"R27-20260923","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ppul.20374","article-title":"Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children.","volume":"41","author":"Lee","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"R28-20260923","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jmii.2019.04.011","article-title":"Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy.","volume":"53","author":"Poddighe","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"R29-20260923","first-page":"2112","article-title":"[Preventive and therapeutic effects and mechanism of Xiaoer Feike Granules on chronic bronchitis induced by lipopolysaccharide in rats].","volume":"46","author":"Zan","year":"2021","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R30-20260923","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4168\/aair.2012.4.2.92","article-title":"Mycoplasma pneumoniae infection affects the serum levels of vascular endothelial growth factor and interleukin-5 in atopic children.","volume":"4","author":"Jeong","year":"2012","journal-title":"Allergy Asthma Immunol Res"},{"key":"R31-20260923","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1515\/cclm-2023-0086","article-title":"Why C-reactive protein is one of the most requested tests in clinical laboratories?","volume":"61","author":"Plebani","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"R32-20260923","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3345\/kjp.2018.61.8.258","article-title":"Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia.","volume":"61","author":"Jeong","year":"2018","journal-title":"Korean J Pediatr"},{"key":"R33-20260923","first-page":"44","article-title":"Treatment of 98 cases of acute bronchitis in infants and young children with Xiaoer Feike granules.","volume":"16","author":"Qian","year":"2018","journal-title":"Chin Med Modern Distance Educ China"},{"key":"R34-20260923","first-page":"1","article-title":"Guidelines for diagnosis and treatment of infantile pneumonia and asthma.","volume":"4","author":"Wang","year":"2008","journal-title":"J Pediatr Tradit Chin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:00:46Z","timestamp":1790186446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":34,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044287","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}